Chronic Periodontitis Clinical Trial
Official title:
Effect of Nonsurgical Periodontal Therapy Verses Oral Hygiene Instructions on Clinical Parameters as Well as Immunological and Microbial Profile of Patients With Chronic Periodontitis
Periodontitis, a bacterial dental biofilm based infectious disease, is a chronic
inflammatory disease of the periodontium which results in irreversible destruction of
supporting structures of the teeth such as periodontal ligaments, connective tissues,
cementum and alveolar bone. More than 700 species of bacteria are estimated to be found in
the sub-gingival dental biofilm in which periodontopathogens are found to be responsible in
initiating periodontal disease. Chronic periodontitis, although termed as 'chronic', starts
as an acute inflammation. Low levels of bacteremia and endotoxins provides a stimulus for
the systemic inflammatory response. In periodontitis, the interaction of lipopolysaccharide
(LPS) from gram-negative bacteria with host cells initiates the secretion of cytokines and
the expression of cell adhesion molecules in gingival tissue which leads to loss of alveolar
bone and connective tissues supporting the teeth.
In the management of chronic periodontitis, non surgical periodontal therapy (NSPT) which
includes oral hygiene instruction (OHI), scaling and root planing, is administered to
improve clinical parameters as well as controlling the bacterial count responsible in
initiating the disease and the resultant inflammatory response. Success of the treatment can
be analyzed when the clinical parameters, counts of the microbes is reduced and inflammatory
response is controlled. Studies which have evaluated the microbiological and immunological
response following NSPT clearly demonstrates an improvement in clinical parameters,
reduction in inflammatory mediators present as well as a decrease in microbial count.
OHI which includes tooth brushing and inter-dental cleaning is found beneficial in removing
microbial plaque, thus, preventing periodontal diseases such as gingivitis and
periodontitis. Studies have evaluated the role of OHI on clinical and immunological
parameters and microbiological profiles of periodontal maintenance subjects, while none of
them evaluated its role alone in the management of chronic periodontitis subjects.
Therefore, the purpose of the following investigation was to compare the changes in the
clinical parameters, inflammatory mediators as well as level and frequency of detection of
periodontopathogens that take place after 3-months of NSPT versus OHI and to evaluate if
clinical parameters have an effect on these inflammatory mediators and microbiological
changes.
Subjects with moderate to advanced chronic periodontitis were selected for this longitudinal
randomized clinical trial. Ethical clearance for the study was granted by the Medical Ethics
Committee, Faculty of Dentistry, University of Malaya [Medical Ethics Committee Number: DF
PE1002/0045(P)]. The study was conducted in accordance with the Helsinki Declaration of
1975, as revised in 2000. The CONSORT guidelines for clinical trials were followed.
Out of 112 screened patients 56 patients fulfilled the inclusion and exclusion criteria.
Inclusion criteria were minimum of 12 teeth present with pocket of 5mm or more and probing
attachment loss of 4mm or more in at least 2 different quadrants which bled on probing.
Exclusion criteria included history of cardiovascular problems, pregnancy, smokers, and
subjects receiving antibiotics in past 4 months or NSPT in past 6 months. Recruited patients
were treated at the Periodontology clinic, Faculty of Dentistry, University of Malaya. Using
Cohen's d formula it was calculated that at least 26 patients would be needed per treatment
group to detect this difference with 80% power.
Prior to baseline examination, patients were assigned in the NSPT and OHI group using block
randomization. Patients in NSPT group received OHI, scaling and root planing followed by
0.12% Chlorhexidine mouth rinses while patients in OHI group received OHI only. At each
month recall visit, participants in both groups were reviewed and motivated. Professional
prophylaxis was only received by NSPT group. Two calibrated examiners (RPCR and WNAWA)
performed all treatment on the patients. Probing pocket depth ( PPD), probing attachment
loss (PAL), gingival bleeding index (BI) and visible plaque index (PI) were determined on
all present teeth except third molars at baseline and 3 months after therapy. For PI and BI,
4 sites were measured (mesial, distal, buccal, lingual) and for PPD and PAL 6 sites were
recorded (disto-buccal, mid-buccal, mesio-buccal, mesio-lingual, mid-lingual and
disto-lingual). Utilizing Kappa statistics, good agreements (>0.8) were obtained for intra
and inter operator reproducibility of all recorded clinical parameters.
Identification of subgingival microbiota using quantitative polymerase chain reaction
technique.
Sub-gingival plaque scraping samples were obtained at baseline and 3-months post therapy
with sterile curettes from the deepest sites at each quadrant and were pooled together for
each subject. Prior to sampling, isolation was maintained with cotton rolls and
supra-gingival plaque was removed using cotton pellets. Plaque scrapings were re-suspended
in 1.5 ml of Phosphate Buffered Saline and stored at -80⁰C freezer prior to DNA extraction.
100µl of plaque sample was used for automated DNA extraction in the lab using the Qiacube
machine (Qiagen®, Biotechnology, Netherlands). The tubes containing the plaque samples were
centrifuged at a speed of 5,000 × g for 10 minutes on a tabletop centrifuge machine to
obtain the pellet. The pellet was then used for automated DNA extraction with the Qiacube
machine. 100µl of eluted DNA was stored in -20⁰C for bacterial detection using quantitative
polymerase chain reaction (Applied Biosystem, USA).
Reference bacterial strains used in this study were P.gingivalis (W83),
A.actinomycetemcomitans (NCTC9710), P.intermedia (ATCC25611) and T.forsythia (CCUG 21028AT).
All the bacterial strains were grown as recommended by American Type Culture Collection
(ATCC). After the growth of bacteria till late exponential phase they were washed with
sterile distilled water and DNA extraction was carried out using the same protocol as for
plaque samples.
The concentration and purity of extracted DNA was determined using spectrophotometer machine
(Nanodrop 2000, Thermo scientific, USA). DNA concentration from both plaque samples and
reference strain were calculated and recorded accordingly. The extracted DNAs were stored in
-20⁰C until the initiation of quantitative polymerase chain reaction procedure.
The protocol given by Boutaga et al., (2005) was followed for quantitative polymerase chain
reaction . Primers and probes selected for this study are shown in Table 1. A total reaction
mixture of 20ul was used for amplification, which contains 2ul of template DNA from plaque
sample/reference strain,10 ul of 2 x TaqMan fast advanced master mix (Applied biosystems,
USA), 1ul of 20x gene expression assay and 7ul nuclease free water. All the components of
reaction mixture except for DNA sample were added in 1.5ml micro centrifuge tube. The tube
was vortexed and than centrifuged to eliminate air bubbles. Mixture was transferred to
96-well plate with addition of 2ul DNA sample. The Plate was then covered with optical
adhesive and centrifuged again to make sure air bubbles are eliminated. The cycling
conditions used were as follows: 50oc for 2min and 95oc for 10min followed by 45 cycles at
95oc for 15s and 60oc for 1min.
Dilutions of known amounts of reference strains of DNA were used to generate standard curves
with correlation coefficient (R2: 0.99). For quantification/copy number determination, the
results from unknown samples were projected on the standard curves obtained from the pure
cultures using the formula: Quantity DNA=10(ct-b)/m.
Determination of Interleukin-1, Interleukin-6, Adiponectin and Tumour Necrosis Factor-alpha
level in Serum.
All reagents were allowed to reach room temperature before use and were gently mixed prior
to the experiments. Number of 8-well strips needed for the assay was determined. 100 ul of
the Standard Diluent Buffer were added to zero wells and 1 well was reserved for chromogen
blank. 100 ul of standards, samples and controls were added to the appropriate microtiter
wells. 50 ul of biotinylated anti-Interleukin-6 (Biotin Conjugate) solution were pipetted
into each well except the chromagen blank and then gently tapped on the side of the plate to
mix. Next, plates were covered with plate covers and incubated for 2 hours at room
temperature. Solutions were thoroughly aspirated from wells and the liquid discarded. The
wells were washed 4 times. 100 ul streptavidin-histidine-rich protein working solution were
added to each well except the chromogen blank. Again, the plates were covered with the plate
covers and incubated for 30 minutes at room temperature. Solution from wells was thoroughly
aspirated and the liquid discarded. The wells were washed 4 times. 100ul of Stabilized
Chromogen was added to each well. The plates were incubated for 30 minutes at room
temperature in the dark. 100 ul of stop solution was added to each well and then gently
tapped on the side of the plate to mix. The absorbance of each well was read at 450 nm
having blanked the plate reader against a chromogen blank composed of 100 ul each of
Stabilized Chromogen and Stop Solution. The absorbance of the standards against the standard
concentration was then plotted on graph paper.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06400069 -
Role of NLRP6 in Chronic Periodontitis
|
||
Completed |
NCT05231096 -
Comparison of the Effect of Gingival Massage of Aloe-vera Gel and Sidr Honey on Chronic Periodontitis
|
N/A | |
Completed |
NCT03203746 -
Gingival Crevicular Fluid Levels of Protein Carbonyl Following the Use of Lycopene in Chronic Periodontitis
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03354338 -
Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy
|
Phase 2 | |
Completed |
NCT02516111 -
Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment
|
Phase 2/Phase 3 | |
Completed |
NCT02174146 -
Leptin and Visfatin in Diabetic Patients With Periodontitis Before and After Periodontal Therapy
|
N/A | |
Terminated |
NCT02568163 -
Influence of Stress on Non Surgical Periodontal Treatment
|
N/A | |
Completed |
NCT02430519 -
Benefits of Platelet Rich Fibrin In Mandibular Molar Furcation Defects
|
N/A | |
Completed |
NCT01233765 -
Analysis of Neutrophil Response in Chronic Periodontitis
|
N/A | |
Completed |
NCT01438333 -
Efficacy of INERSAN in Patients With Chronic Periodontitis as Adjunctive to Full Mouth Disinfection
|
N/A | |
Completed |
NCT02218515 -
Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft
|
Phase 4 | |
Completed |
NCT02197260 -
Antimicrobial Therapy as Adjunct to Periodontal Treatment: Effect of Timing
|
Phase 4 | |
Not yet recruiting |
NCT03270280 -
Comparison of Salivary Interleukin-1β and Matrix Metalloproteinase-8 Levels in Individuals With Chronic Periodontitis
|
Phase 2 | |
Not yet recruiting |
NCT04026828 -
Evaluation of Possible Genes in Periodontal Diseases by Genetic Methods
|
||
Completed |
NCT04643288 -
Nanocrystalline Hydroxyapatite Bone Substitute for Treating Periodontal Intrabony Defects
|
N/A | |
Completed |
NCT04697199 -
The Adjunctive Effect of Probiotics to Non Surgical Treatment of Chronic Periodontitis
|
Phase 1 | |
Completed |
NCT03039244 -
Evaluation of Antimicrobial Photodynamic Therapy as an Adjunct to Periodontal Treatment in Smokers
|
N/A | |
Completed |
NCT02851823 -
Combined Use of Er:YAG and Nd:YAG Laser
|
N/A | |
Completed |
NCT02898675 -
Advantages of Autologous Platelet-Rich Fibrin Membrane on Growth Factor Levels and Periodontal Healing
|
N/A | |
Completed |
NCT03874390 -
Effects of Ozone Therapy on Clinical Parameters and Inflammatory Cytokines in Chronic Periodontitis Patients
|
N/A |